EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
This Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Laurent Chardonnet (“Executive” and, collectively with the Company, the “Parties”), is entered into as of 11/5/2021 | 5:16 PM EDT.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICY DISCLOSED. SINGLE-TENANT TRIPLE NET LEASEAttornment and Non-Disturbance Agreement • March 17th, 2022 • Prelude Therapeutics Inc • Pharmaceutical preparations
This Single-Tenant Triple Net Lease (this “Lease”) is made and entered into as of September 13, 2021 (the “Effective Date”), by and between CRISP PARTNERS LLC, a Delaware limited liability company (“Landlord”), and PRELUDE THERAPEUTICS INCORPORATED, a Delaware corporation (“Tenant”).
FIRST AMENDMENT TO SINGLE-TENANT TRIPLE NET LEASEPrelude Therapeutics Inc • March 17th, 2022 • Pharmaceutical preparations
This FIRST AMENDMENT TO SINGLE-TENANT TRIPLE NET LEASE (the “First Amendment”) is made as of _11/15/2021_, by and between CRISP PARTNERS LLC, a Delaware limited liability company (“Landlord”) and PRELUDE THERAPEUTICS INCORPORATED, a Delaware corporation (“Tenant”).
